The University of Pennsylvania Receives Breakthrough Therapy Designation from the FDA
Tuesday, July 15, 2014
Posted by: ISCT Administrator
The University of Pennsylvania has received Breakthrough Therapy Designation from the FDA. For more information, CLICK HERE.
The FDA has previously granted Breakthrough Therapy to only four other biologic agents and this is the first personalized cell therapy for cancer to obtain it. From October through June 30, the FDA received 20 applications and only 3 were approved, the previous year, 10 of 11 applications were not approved.
|
|
Email to a Friend